Recent Events & Catalysts

1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Brush Off

Yahoo · today

Agilent Technologies (NYSE:A) Shows Strong Breakout Setup with Top-Tier Technical Ratings

ChartMill · today

Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Yahoo · 1d ago

Agilent Receives FDA Approval For The PD‑L1 LHC 28‑8 PharmDx Assay As Companion Diagnostic To Identify Patients With Carcinomas Who May Be Eligible For Treatment With OPDIVO or OPDIVO QVANTIG

Benzinga · 1d ago

Alamar Hits A High Note On Alzheimer's Buzz

Yahoo · 2d ago

Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?

Yahoo · 2d ago

Agilent Strengthens Biopharma Growth Prospects With AI Expansion

Yahoo · 6d ago

Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat

SeekingAlpha · 6d ago

Entry into a material agreement, Creation of a direct financial obligation (new debt), Financial statements and exhibits

Filed 2026-06-25 · 20d ago

Results of operations (earnings release), Departure/appointment of directors or officers, Financial statements and exhibits

Filed 2026-05-27 · 49d ago

Departure/appointment of directors or officers, Regulation FD disclosure, Financial statements and exhibits

Filed 2026-05-04 · 72d ago